Back to Search
Start Over
Efficacy and safety of omalizumab against chronic spontaneous urticaria: Real-world study from China
- Source :
- World Allergy Organization Journal, Vol 15, Iss 12, Pp 100719- (2022)
- Publication Year :
- 2022
- Publisher :
- Elsevier, 2022.
-
Abstract
- Background: Omalizumab is an effective treatment for chronic spontaneous urticaria (CSU) patients aged ≥12 years, but its efficacy in patients aged
Details
- Language :
- English
- ISSN :
- 19394551
- Volume :
- 15
- Issue :
- 12
- Database :
- Directory of Open Access Journals
- Journal :
- World Allergy Organization Journal
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.56918325c4f1fabb9b0da6dcf55e2
- Document Type :
- article
- Full Text :
- https://doi.org/10.1016/j.waojou.2022.100719